Market OverviewNanotechnology-based drug delivery is fast becoming the backbone of modern pharmaceutical innovation, and lipid-based finished dosage forms sit squarely at that frontier. The Liposome And Lipid Nanoparticle FDF Market was valued at 11.94 USD Billion in 2023, rising to 12.83 USD Billion in 2024, and is projected to reach 22.74 USD Billion by 2032, growing at a CAGR of 7.42%. This...